94.18 USD
↘ 5.19 (5.22%)LIVE (AS OF 11:27 AM EST)
Shares of Spyre Therapeutics, Inc. Common Stock (SYRE) are trading at $94.18. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Nov 16, 2026.